Djharker:proven value Review their audited financial statements. The auditors obiviously felt the patents had no proven value. One year there was $375,000 in the asset section. The next year it was written off. The CYGX management could not convince their own auditors the future value of the patents. The auditors probably demanded they write off their value. It appears to me that the stock price and this recent transaction tells the true value of CYGX. Remove all the pumper stories and the real value appears. We could today break the 50 cent barrier. Maybe that stockholder meeting is just in time to removal. The inept management team running this speculative deal into the ground. Excessive stock grants and a high overhead and only 24% invested in research and development are proven grounds for removal. The Hunt family are smart business individuals. They were paid back in cash and got 10% of all future licensing rights for nothing.They made a loan to CYGXThey rode this horse until it was apparent that this antisense SSDNA technology was not going to bear fruit. They got as much as it was worth and went down the road. This is future sign of what the stock price will do when the Sepsis studies failure due to their delivery problems.
Everyone has reasons for the things they do. I cannot say why someone did something or how they value things. The Hunt's were quite off on the silver market if you recall, so i would safely say they don't know all the markets. CYGX fixed an old problem for cheap, look no further. Next thing you know they will get a $1 billion in a licensing deal & you'll say it was worth $2 billion, jeez.
News 
Market Data 
Discover 
AI
